| scholarly article | Q13442814 |
| P50 | author | Jane Anderson | Q21544772 |
| David Chadwick | Q105872460 | ||
| Caroline Sabin | Q42249738 | ||
| Sophie Jose | Q42273712 | ||
| Kholoud Porter | Q53124393 | ||
| Fabiola Martin | Q64918256 | ||
| Chloe Orkin | Q87418404 | ||
| P2093 | author name string | John Walsh | |
| Mark Nelson | |||
| Martin Fisher | |||
| Richard Gilson | |||
| Margaret T May | |||
| Phillip Hay | |||
| Margaret Johnson | |||
| Stephen Kegg | |||
| Clifford Leen | |||
| Adrian Palfreeman | |||
| Frank Post | |||
| Jonathan Ainsworth | |||
| Mark Gompels | |||
| Teresa Hill | |||
| Valerie Delpech | |||
| UK Collaborative HIV Cohort (UK CHIC) Study | |||
| P2860 | cites work | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
| Prevention of HIV-1 infection with early antiretroviral therapy | Q24634688 | ||
| Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis | Q24672191 | ||
| Inflammation, coagulation and cardiovascular disease in HIV-infected individuals | Q28483645 | ||
| Hepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) study | Q28484920 | ||
| Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE) | Q28534394 | ||
| Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis | Q28742423 | ||
| Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data | Q28742740 | ||
| Adherence to HIV combination therapy | Q33906463 | ||
| Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDS | Q33916321 | ||
| Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies | Q34139859 | ||
| Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies | Q34228103 | ||
| Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers | Q34802684 | ||
| Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries | Q35057962 | ||
| Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs | Q35147189 | ||
| Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies | Q35169664 | ||
| Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study | Q35316315 | ||
| The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis | Q35864053 | ||
| Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. | Q35867142 | ||
| Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies | Q36285986 | ||
| Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD). | Q36502616 | ||
| British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). | Q36653838 | ||
| Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies | Q36919443 | ||
| HIV/AIDS, comorbidity, and alcohol: can we make a difference? | Q37011927 | ||
| The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK - trends in HCV testing and the impact of HCV on HIV treatment outcomes | Q38448333 | ||
| Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study | Q42282082 | ||
| Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population | Q43771023 | ||
| All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration | Q47918470 | ||
| Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy. | Q51563023 | ||
| Predictors identified for losses to follow-up among HIV-seropositive patients | Q56837841 | ||
| The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study | Q57181218 | ||
| Projected life expectancy of people with HIV according to timing of diagnosis | Q57476832 | ||
| Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort | Q81600690 | ||
| High-risk drug practices tighten grip on London gay scene | Q85898081 | ||
| New HIV diagnoses in London's gay men continue to soar | Q87172246 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| life expectancy | Q188419 | ||
| viral load | Q2528140 | ||
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | 1193-1202 | |
| P577 | publication date | 2014-05-01 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy | |
| P478 | volume | 28 |
| Q51740334 | "[Drinking is] Like a Rule That You Can't Break": Perceived Barriers and Facilitators to Reduce Alcohol Use and Improve Antiretroviral Treatment Adherence Among People Living with HIV and Alcohol Use Disorder in Vietnam. |
| Q64073051 | 'Just another vial…': a qualitative study to explore the acceptability and feasibility of routine blood-borne virus testing in an emergency department setting in the UK |
| Q42359618 | 2-Drug regimens in HIV treatment: pharmacological considerations |
| Q36144465 | A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"? |
| Q37264576 | A Direct Comparison of Two Densely Sampled HIV Epidemics: The UK and Switzerland |
| Q40413594 | A Pilot Trial Examining African American and White Responses to Algorithm-Guided Smoking Cessation Medication Selection in Persons Living with HIV. |
| Q54211761 | A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population. |
| Q55496714 | A scoping review of the role of HIV-related stigma and discrimination in noncommunicable disease care. |
| Q93013679 | A two-drug regimen for antiretroviral therapy |
| Q36650552 | Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort Study |
| Q40182120 | Access to fertility services in Canada for HIV-positive individuals and couples: a comparison between 2007 and 2014. |
| Q56991795 | Achieving the fourth 90: healthy aging for people living with HIV |
| Q64126017 | Adherence and viral suppression among participants of the Patient-centered HIV Care Model project-a collaboration between community-based pharmacists and HIV clinical providers |
| Q38259404 | Advance directives among people living with HIV: room for improvement |
| Q47156382 | Antifungal Activity of Plasmacytoid Dendritic Cells and the Impact of Chronic HIV Infection. |
| Q60920247 | Antiretroviral Drug Use and HIV Drug Resistance Among Young Women in Rural South Africa: HPTN 068 |
| Q89836084 | Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial |
| Q39061949 | Antiretroviral therapy options for treatment-naive patients with HIV-1. |
| Q64067308 | Assessment of trabecular bone score, an index of bone microarchitecture, in HIV positive and HIV negative persons within the HIV UPBEAT cohort |
| Q37677218 | Association between engagement in-care and mortality in HIV-positive persons |
| Q92590350 | Association of single nucleotide polymorphisms with dyslipidemia in antiretroviral exposed HIV patients in a Ghanaian population: A case-control study |
| Q30245414 | Barriers to HIV Cure |
| Q38729837 | Behavioural, not biological, factors drive the HCV epidemic among HIV-positive MSM: HCV and HIV modelling analysis including HCV treatment-as-prevention impact |
| Q57180790 | British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015 |
| Q39686508 | Can sugarcoated fingerprints be used to identify lurking viruses? |
| Q90026497 | Cardiovascular Risk Assessment Varies Widely by Calculator and Race/Ethnicity in a Majority Latinx Cohort Living with HIV |
| Q47651355 | Cardiovascular disease prevention policy in HIV: recommendations from a modelling study |
| Q28553516 | Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy |
| Q37381433 | Changes in coronary heart disease risk profiles of HIV patients in Zimbabwe over 9 months: a follow-up study |
| Q95355768 | Chromatin Regulation and the Histone Code in HIV Latency |
| Q91768229 | Chronic Disease Onset Among People Living with HIV and AIDS in a Large Private Insurance Claims Dataset |
| Q41449893 | Clinical outcomes of first-line antiretroviral therapy in Latin America: analysis from the LATINA retrospective cohort study. |
| Q40979736 | Clinical progression of severely immunosuppressed HIV-infected patients depends on virological and immunological improvement irrespective of baseline status |
| Q50149700 | Cocaine use may induce telomere shortening in individuals with HIV infection |
| Q97073462 | Cognitive disorders in people living with HIV |
| Q35124919 | Community perspective on the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. |
| Q39929987 | Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT Trial |
| Q35567815 | Cost and safety of assisted reproductive technologies for human immunodeficiency virus-1 discordant couples |
| Q49334645 | Cost-effective osteoporosis treatment thresholds for people living with HIV infection in Greece |
| Q60043899 | Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study |
| Q36197957 | Dentistry and HIV/AIDS related stigma. |
| Q37696485 | Development and application of a new measure of engagement in out-patient HIV care. |
| Q58588891 | Development of an mHealth platform for HIV Care: Gathering User Perspectives Through Co-Design Workshops and Interviews |
| Q59356122 | Differential contribution of chronic binge alcohol and antiretroviral therapy to metabolic dysregulation in SIV-infected male macaques |
| Q42201270 | Does HIV antiretroviral therapy still need its backbone? |
| Q37138907 | Does systemic inflammation and immune activation contribute to fracture risk in HIV? |
| Q51196202 | Early antiretroviral therapy and potent second-line drugs could decrease HIV incidence of drug resistance. |
| Q61798519 | Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men |
| Q40746082 | Effects of CD4 Cell Counts and Viral Load Testing on Mortality Rates in Patients With HIV Infection Receiving Antiretroviral Treatment: An Observational Cohort Study in Rural Southwest China |
| Q40883096 | Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men. |
| Q102206026 | Estimates of the global burden of cervical cancer associated with HIV |
| Q92277511 | Excess Risk for Atherosclerotic Cardiovascular Outcomes Among US Adults With HIV in the Current Era |
| Q47577283 | Exercise and mental health of people living with HIV: A systematic review |
| Q59352091 | Expectant management surveillance for patients at risk for invasive squamous cell carcinoma of the anus: a large US healthcare system experience |
| Q56911620 | Expert consensus statement on the science of HIV in the context of criminal law |
| Q40896265 | Extremely high HIV-1 viral load in a patient with undiagnosed clinical indicator disease for HIV infection |
| Q41923748 | Fostering a "Feeling of Worth" Among Vulnerable HIV Populations: The Role of Linkage to Care Specialists |
| Q35763402 | Four-Stage Audit Demonstrating Increased Uptake of HIV Testing in Acute Neurology Admissions Using Staged Practical Interventions |
| Q58539497 | From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors |
| Q91938838 | GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds |
| Q57180752 | Gray and White Matter Abnormalities in Treated Human Immunodeficiency Virus Disease and Their Relationship to Cognitive Function |
| Q28073408 | Guidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive Individuals |
| Q47292815 | HIV and the menopause: A review. |
| Q90219672 | HIV viral load testing coverage and timeliness after implementation of the wellness anniversary in a paediatric and adolescent HIV clinic in KwaZulu-Natal, South Africa |
| Q51760388 | HIV-associated cognitive performance and psychomotor impairment in a Thai cohort on long-term cART. |
| Q40045231 | High levels of viral suppression among East African HIV-infected women and men in serodiscordant partnerships initiating antiretroviral therapy with high CD4 counts and during pregnancy |
| Q41986511 | Higher Levels of CYSTATIN C in HIV/AIDS Patients with Metabolic Syndrome. |
| Q94393065 | Highlights from the BHIVA Satellite Symposium, IAS Conference, Paris, France, July 2017: 'Tougher times: adapting to increasing demand with declining resources' |
| Q30252460 | Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines |
| Q60929848 | Human Immunodeficiency Virus and Trans Women: A Literature Review |
| Q36378109 | Human immunodeficiency virus and liver disease: An update |
| Q36171153 | Immune recovery in acute and chronic HIV infection and the impact of thymic stromal lymphopoietin |
| Q39170367 | Immunosenescence and hurdles in the clinical management of older HIV-patients |
| Q41387994 | Impact of TB on the survival of people living with HIV infection in England, Wales and Northern Ireland. |
| Q91983222 | Impact of musculoskeletal symptoms on physical functioning and quality of life among treated people with HIV in high and low resource settings: A case study of the UK and Zambia |
| Q33611467 | Impairments of Motor Function While Multitasking in HIV. |
| Q37613237 | Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir |
| Q92915228 | Incidence and predictors of loss to follow up among adult HIV patients on antiretroviral therapy in University of Gondar Comprehensive Specialized Hospital: A competing risk regression modeling |
| Q37316732 | Is HIV Painful? An Epidemiologic Study of the Prevalence and Risk Factors for Pain in HIV-infected Patients |
| Q36360961 | Joint analysis of longitudinal and survival AIDS data with a spatial fraction of long-term survivors: A Bayesian approach |
| Q90588130 | Knowledge and perception on type2 diabetes and hypertension among HIV clients utilizing care and treatment services: a cross sectional study from Mbeya and Dar es Salaam regions in Tanzania |
| Q95360885 | Life expectancy and years of life lost in HIV patients under the care of BandarAbbas Behavioral Disorders Counseling Center |
| Q37636104 | Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population |
| Q38405857 | Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis |
| Q55260301 | Lymph Node Cellular and Viral Dynamics in Natural Hosts and Impact for HIV Cure Strategies. |
| Q89522543 | Management of HIV-infected patients in the intensive care unit |
| Q37578291 | Mechanisms of Accelerated Liver Fibrosis Progression during HIV Infection. |
| Q28551803 | Modeling the Slow CD4+ T Cell Decline in HIV-Infected Individuals |
| Q38461294 | Monitoring of kidney function in HIV-positive patients. |
| Q51777203 | Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort. |
| Q89627154 | Mortality and causes of death in people living with HIV in the era of combination antiretroviral therapy compared with the general population in Japan |
| Q33668524 | Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care |
| Q58806024 | Non-AIDS Mortality Is Higher Among Successfully Treated People Living with HIV Compared with Matched HIV-Negative Control Persons: A 15-Year Follow-Up Cohort Study in Sweden |
| Q91917059 | Nonadherence to Any Prescribed Medication Due to Costs Among Adults with HIV Infection - United States, 2016-2017 |
| Q64079045 | Noncommunicable disease burden among HIV patients in care: a national retrospective longitudinal analysis of HIV-treatment outcomes in Kenya, 2003-2013 |
| Q39453985 | Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence |
| Q39093575 | Obesity in the HIV-infected population in Northeast England: a particular issue in Black-African women |
| Q30240606 | Osteoporosis in postmenopausal women living with HIV |
| Q40062892 | Out of focus: tailoring the cascade of care to the needs of women living with HIV. |
| Q92570766 | PRIME (Positive Transitions Through the Menopause) Study: a protocol for a mixed-methods study investigating the impact of the menopause on the health and well-being of women living with HIV in England |
| Q92758627 | Palliative care guidelines for the management of HIV-infected people in South Africa |
| Q35738366 | People with diagnosed HIV infection not attending for specialist clinical care: UK national review |
| Q42390812 | Preexposure Prophylaxis and Patient Centeredness: A Call for Holistically Protecting and Promoting the Health of Gay Men. |
| Q38267445 | Preserving HIV-specific T cell responses: does timing of antiretroviral therapy help? |
| Q47602080 | Prevalence and Correlates of Smoking Among People Living With HIV in South Africa |
| Q38613712 | Prevalence, patterns, and perceived value of complementary and alternative medicine among HIV patients: a descriptive study. |
| Q61446561 | Progress in the HIV epidemic: Identifying goals and measuring success |
| Q38836871 | Protecting bone in long-term HIV positive patients receiving antiretrovirals |
| Q39891537 | Receipt of clinical and prevention services, clinical outcomes, and sexual risk behaviors among HIV-infected young adults in care in the United States |
| Q30235024 | Recent Insights into the HIV/AIDS Pandemic |
| Q37046208 | Reduced healthcare utilization following successful hepatitis C virus treatment in HIV-co-infected patients with mild liver disease |
| Q42149889 | Reductions in virological failure and drug resistance in Chinese antiretroviral-treated patients due to lamivudine-based regimens, 2003-12. |
| Q54240869 | Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV. |
| Q38837077 | Renal effects of novel antiretroviral drugs |
| Q36783202 | Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies |
| Q88561154 | Reproductive Desires and Considerations of HIV-Positive Men in Heterosexual Relationships in New York City |
| Q90088151 | Resource utilization across the continuum of HIV care: An emergency department-based cohort study |
| Q38802093 | Rilpivirine, emtricitabine and tenofovir alafenamide: single-tablet combination for the treatment of HIV-1 infection in selected patients |
| Q36153952 | Risk Factors for Non-Adherence to cART in Immigrants with HIV Living in the Netherlands: Results from the ROtterdam ADherence (ROAD) Project |
| Q35661739 | Risk factors for early mortality after AIDS in the cART era: A population-based cohort study in Italy |
| Q98499825 | Risk of prostate cancer in men with HIV/AIDS: a systematic review and meta-analysis |
| Q40048428 | Routine monitoring and assessment of adults living with HIV: results of the British HIV Association (BHIVA) national audit 2015. |
| Q36479966 | Running Backwards: Consequences of Current HIV Incidence Rates for the Next Generation of Black MSM in the United States |
| Q39157929 | Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial |
| Q44203354 | Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning. |
| Q37098390 | Second European Round Table on the Future Management of HIV: 10-11 October 2014, Barcelona, Spain |
| Q42334793 | Serum lipid and glucose profiles in HIV-positive Nigerian children |
| Q64965078 | Severe Acute Kidney Injury and Double Tubulopathy Due to Dual Toxicity Caused by Combination Antiretroviral Therapy. |
| Q38561454 | Significant publications on infectious diseases pharmacotherapy in 2014. |
| Q91750225 | Spatial distribution and characteristics of HIV clusters in Ethiopia |
| Q52720854 | Stroke in Human Immunodeficiency Virus-infected Individuals in Sub-Saharan Africa (SSA): A Systematic Review. |
| Q28555090 | Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics |
| Q93185836 | Survival Time and Prognostic Factors of Mortality among Patients with Acquired Immunodeficiency Syndrome in North-East Peninsular Malaysia |
| Q38813848 | Switching regimens in virologically suppressed HIV-1-infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimens |
| Q36661588 | Systemic Cytokine Levels Do Not Predict CD4(+) T-Cell Recovery After Suppressive Combination Antiretroviral Therapy in Chronic Human Immunodeficiency Virus Infection |
| Q36290647 | The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1. |
| Q90527247 | The People Living with HIV STIGMASurvey UK 2015: Stigmatising experiences and dental care |
| Q36385895 | The Role of Early HIV Status Disclosure in Retention in HIV Care |
| Q57463885 | The association of therapeutic versus recreational marijuana use and antiretroviral adherence among adults living with HIV in Florida |
| Q57773425 | The biopolitics of engagement and the HIV cascade of care: a synthesis of the literature on patient citizenship and antiretroviral therapy |
| Q40045681 | The changing face of an epidemic: healthy old age with HIV. |
| Q52567034 | The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco. |
| Q64243761 | The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV |
| Q34517842 | The effect of adherence to guidelines for initial antiretroviral therapy on 1-year outcomes: a French cohort study |
| Q55384034 | The immune profile in HIV: A useful signature in future HIV research? |
| Q37136239 | The menopause transition in women living with HIV: current evidence and future avenues of research |
| Q38764695 | The role of tenofovir alafenamide in future HIV management |
| Q93036165 | The value of hope: development and validation of a contextual measure of hope among people living with HIV in urban Tanzania a mixed methods exploratory sequential study |
| Q94546211 | Tobacco smoking and associated factors in human immunodeficiency virus-infected adults attending human immunodeficiency virus clinics in the Western Cape province, South Africa |
| Q96127134 | Trends and causes of mortality in a population-based cohort of HIV-infected adults in Spain: comparison with the general population |
| Q38794124 | Trends in ART Prescription and Viral Suppression Among HIV-Positive Young Adults in Care in the United States, 2009-2013. |
| Q39621488 | Trends in Racial and Ethnic Disparities in Antiretroviral Therapy Prescription and Viral Suppression in the United States, 2009-2013. |
| Q59350322 | Trends in provider-advised HIV antiretroviral therapy deferral in the United States, 2009-2014 |
| Q33697163 | Tryptophan catabolism and immune activation in primary and chronic HIV infection |
| Q37205880 | Understanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression Among HIV Patients in the United States |
| Q28595560 | Use Your Words Carefully: What Is a Chronic Disease? |
| Q36608028 | Use and Predictors of End-of-Life Care Among HIV Patients in a Safety Net Health System |
| Q101574365 | Validation of the BD FACSPresto system for the measurement of CD4 T-lymphocytes and hemoglobin concentration in HIV-negative and HIV-positive subjects |
| Q47100624 | mHealth Interventions To Support Self-Management In HIV: A Systematic Review |
Search more.